A Characterization and Targeting of the Infarct Border Zone in a Swine Model of Myocardial Infarction

Clinical and Translational Science

Volumn 5, Issue 5, 2012, Pages 416-421

  Duran, Jason M ^a   Taghavi, Sharven ^a   Berretta, Remus M ^a   Makarewich, Catherine A ^a   Sharp III, Thomas ^a   Starosta, Tim ^a   Udeshi, Foram ^a   George, Jon C ^a   Kubo, Hajime ^a   Houser, Steven R ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac; Myocardial infarction; Translational research

Indexed keywords

CASPASE 3; MICROSPHERE; PHOSPHOLAMBAN; PROTEIN KINASE B; PROTEIN S6; RYANODINE RECEPTOR;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON; CELL VIABILITY; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVATION; FLUORESCENCE ANALYSIS; HEART MUSCLE CELL; HISTOPATHOLOGY; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; INFARCT BORDER ZONE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NOGA THREE DIMENSIONAL LEFT VENTRICULAR ELECTROMECHANICAL MAPPING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SWINE; TRANSTHORACIC ECHOCARDIOGRAPHY; WESTERN BLOTTING;

ANIMALS; BIOMECHANICS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE; HEART FUNCTION TESTS; MYOCARDIAL INFARCTION; PHOSPHOSERINE; SUS SCROFA;

ANIMALIA; SUIDAE;

EID: 84867721158     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2012.00432.x     Document Type: Article

References (30)

1. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li Baosheng, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001: 410; 701-705.
2. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, et al. Human cardiac stem cells. Proc Nat Acad Sci USA. 2007: 104(35); 14068-14073.
3. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenber S, Lippolt P, Breidenbach C, Fichter S, Korte T, Hornig B, Messinger D, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004: 364; 141-148.
4. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht Rainer, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CQ, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006: 355(12); 1210-1221.
5. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomized phase 1 trial. Lancet. 2011: 378(9806); 1847-1857.
6. Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET, Yeung AC, Johnstone BH, Yock PG, March KL. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation. 2005; 112: I150-I156.
7. Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, Iaffaldano G, Padin-Iruegas ME, Gonzalez A, Rizzi R, et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Nat Acad Sci USA. 2007: 104(45); 17783-17788.
8. Xu M, Wani M, Dai YS, Wang J, Yan M, Ayub A, Ashraf M. Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation. 2004: 110(17); 2658-2665.
9. Tulloch NL, Muskheli V, Razumova MV, Korte SF, Regnier M, Hauch KD, Pabon L, Reinecke H, Murry CE. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res. 2011; 109(1): 47-59.
10. Segers VFM, Lee RT. Biomaterials to enhance stem cell function in the heart. Circ Res. 2011; 109(8): 910-922.
11. Ngyuen PK, Lan F, Wang Y, Wu JC. Imaging: Guiding the clinical translation of cardiac stem cell therapy. Circ Res. 2011; 109: 962-979.
12. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998; 98(25): 2800-2804.
13. Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 2007; 21(12): 3197-3207.
14. Gyongyosi M, Dib N. Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease. Nat Rev Cardiol. 2011; 8: 393-404.
15. Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N, Schatz RA, Asahara T, Isner JM, Kuntz RE. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation. 2002; 105(17): 2012-2018.
16. Gyongyosi M, Glogar HD. Non-fluoroscopic catheter-based endocardial mapping and mapping-guided percutaneous transmyocardial revascularization. Austrian J Kardiol. 2001: 8; 503-508.
17. Willerson JT, Perin EC, Ellis SG, Pepine CJ, Henry TD, Zhao DX, Lai D, Penn MS, Byrne BJ, Silva G, et al. Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): rationale and design. Am Heart J. 2010; 160: 215-223.
18. Losordo DW, Henry TD, Davidson C, Lee JS, Costa MA, Bass T, Mendelsohn F, Fortuin DF, Pepine CJ, Traverse JH, et al. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res. 2011; 209(4): 428-436.
19. Schiller NB, SP, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 5(2): 358-367.
20. Kubo H, Marulies KB, Piacentino VIII, Gaughan JP, Houser SR. Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation. 2001; 104(9): 1012-1018.
21. Hagemann D, Kuschel M, Kuramochi T, Zhu W, Cheng H, Xiao RP. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J Biol Chem. 2000; 275: 22532-22536.
22. Port JD, Bristow MR. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol. 2001; 33: 887-905.
23. Mundina-Weilenmann C, Said M, Vittone L, Ferrero P, Mattiazzi A. Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a beta-adrenergic challenge. Mol Cell Biochem. 2003; 252: 239-246.
24. Peterson RT, Schreiber SL. Translation control: connecting mitogens and the ribosome. Curr Biol. 1998; 8(7): R248-R250.
25. Rota M, Boni A, Urbanek K, Padin-Iruegas E, Kajstura TJ, Fiore G, Kubo H, Sonnenblick EH, Musso E, Houser SR. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circulation Research. 2005; 97: 1332-1341.
26. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem. 1994; 269(49): 30761-30764.
27. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the b-adrenergic pathway. Circulation. 1998; 98: 1329-1334.
28. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. b-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol Heart Circ Physiol. 1998; 275: H961-H968.
29. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: should the paradigm be expanded? Circulation. 1989; 79: 441-444.
30. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990; 81: 1161-1172.